Venkataraman Balasubramanian
Examiner (ID: 17374, Phone: (571)272-0662 , Office: P/1624 )
Most Active Art Unit | 1624 |
Art Unit(s) | 1624, 1611 |
Total Applications | 2999 |
Issued Applications | 2017 |
Pending Applications | 254 |
Abandoned Applications | 728 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 588025
[patent_doc_number] => 07439235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-21
[patent_title] => 'Method for obtaining estrogens from mare\'s urine'
[patent_app_type] => utility
[patent_app_number] => 10/857355
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7062
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/439/07439235.pdf
[firstpage_image] =>[orig_patent_app_number] => 10857355
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/857355 | Method for obtaining estrogens from mare's urine | May 31, 2004 | Issued |
Array
(
[id] => 860498
[patent_doc_number] => 07371741
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-13
[patent_title] => 'Estradiol derivatives and pharmaceutical compositions using same'
[patent_app_type] => utility
[patent_app_number] => 10/856340
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17608
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/371/07371741.pdf
[firstpage_image] =>[orig_patent_app_number] => 10856340
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/856340 | Estradiol derivatives and pharmaceutical compositions using same | May 27, 2004 | Issued |
Array
(
[id] => 7265013
[patent_doc_number] => 20040242549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Neuroactive 13, 24-cyclo-18, 21-dinorcholanes and structurally related pentacyclic steroids'
[patent_app_type] => new
[patent_app_number] => 10/856314
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 34649
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242549.pdf
[firstpage_image] =>[orig_patent_app_number] => 10856314
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/856314 | Neuroactive 13, 24-cyclo-18, 21-dinorcholanes and structurally related pentacyclic steriods | May 27, 2004 | Issued |
Array
(
[id] => 7378059
[patent_doc_number] => 20040220156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Novel anti-inflammatory androstane derivative compositions'
[patent_app_type] => new
[patent_app_number] => 10/853500
[patent_app_country] => US
[patent_app_date] => 2004-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12353
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220156.pdf
[firstpage_image] =>[orig_patent_app_number] => 10853500
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/853500 | Novel anti-inflammatory androstane derivative compositions | May 24, 2004 | Abandoned |
Array
(
[id] => 6939791
[patent_doc_number] => 20050113354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Bioavailable prodrugs of androgenic steroids and related method'
[patent_app_type] => utility
[patent_app_number] => 10/854028
[patent_app_country] => US
[patent_app_date] => 2004-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7089
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113354.pdf
[firstpage_image] =>[orig_patent_app_number] => 10854028
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/854028 | Bioavailable prodrugs of androgenic steroids and related method | May 24, 2004 | Abandoned |
Array
(
[id] => 7378022
[patent_doc_number] => 20040220150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => '7-Phenyl-substituted tetracycline compounds'
[patent_app_type] => new
[patent_app_number] => 10/853536
[patent_app_country] => US
[patent_app_date] => 2004-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10067
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220150.pdf
[firstpage_image] =>[orig_patent_app_number] => 10853536
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/853536 | 7-Phenyl-substituted tetracycline compounds | May 23, 2004 | Abandoned |
Array
(
[id] => 7435983
[patent_doc_number] => 20040210096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Bromination process'
[patent_app_type] => new
[patent_app_number] => 10/845801
[patent_app_country] => US
[patent_app_date] => 2004-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6464
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20040210096.pdf
[firstpage_image] =>[orig_patent_app_number] => 10845801
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/845801 | Bromination process | May 13, 2004 | Issued |
Array
(
[id] => 5085884
[patent_doc_number] => 20070275935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Estratriene Derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/556362
[patent_app_country] => US
[patent_app_date] => 2004-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 39844
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275935.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556362
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556362 | Estratriene Derivatives | May 12, 2004 | Abandoned |
Array
(
[id] => 7401951
[patent_doc_number] => 20040175314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Self-reducing anthraquinone compounds'
[patent_app_type] => new
[patent_app_number] => 10/472549
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5753
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20040175314.pdf
[firstpage_image] =>[orig_patent_app_number] => 10472549
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/472549 | Self-reducing anthraquinone compounds | May 11, 2004 | Abandoned |
Array
(
[id] => 7062019
[patent_doc_number] => 20050004382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Meiosis regulating compounds'
[patent_app_type] => utility
[patent_app_number] => 10/843488
[patent_app_country] => US
[patent_app_date] => 2004-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21767
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004382.pdf
[firstpage_image] =>[orig_patent_app_number] => 10843488
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/843488 | Meiosis regulating compounds | May 10, 2004 | Abandoned |
Array
(
[id] => 7061726
[patent_doc_number] => 20050004088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Hormonal contraceptive product'
[patent_app_type] => utility
[patent_app_number] => 10/841278
[patent_app_country] => US
[patent_app_date] => 2004-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3438
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004088.pdf
[firstpage_image] =>[orig_patent_app_number] => 10841278
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/841278 | Hormonal contraceptive product | May 6, 2004 | Abandoned |
Array
(
[id] => 7319026
[patent_doc_number] => 20040224933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Novel process and intermediates for preparing 17-halogenated 19-norsteroid compounds'
[patent_app_type] => new
[patent_app_number] => 10/834638
[patent_app_country] => US
[patent_app_date] => 2004-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4461
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224933.pdf
[firstpage_image] =>[orig_patent_app_number] => 10834638
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/834638 | Process and intermediates for preparing 17-halogenated 19-norsteroid compounds | Apr 28, 2004 | Issued |
Array
(
[id] => 7427025
[patent_doc_number] => 20040229853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Novel method and intermediates for preparing 19-norsteroid compounds'
[patent_app_type] => new
[patent_app_number] => 10/834749
[patent_app_country] => US
[patent_app_date] => 2004-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11871
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229853.pdf
[firstpage_image] =>[orig_patent_app_number] => 10834749
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/834749 | Novel method and intermediates for preparing 19-norsteroid compounds | Apr 28, 2004 | Abandoned |
Array
(
[id] => 7070080
[patent_doc_number] => 20050245465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Compounds for treating Alzheimer\'s disease and for inhibiting beta-amyloid peptitde production'
[patent_app_type] => utility
[patent_app_number] => 10/834773
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 10092
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20050245465.pdf
[firstpage_image] =>[orig_patent_app_number] => 10834773
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/834773 | Compounds for treating Alzheimer's disease and for inhibiting beta-amyloid peptitde production | Apr 27, 2004 | Abandoned |
Array
(
[id] => 7011419
[patent_doc_number] => 20050065135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => '8beta-Vinyl-11beta-(omega-substituted)alkyl-estra-1,3,5(10)-trienes'
[patent_app_type] => utility
[patent_app_number] => 10/829390
[patent_app_country] => US
[patent_app_date] => 2004-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18440
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20050065135.pdf
[firstpage_image] =>[orig_patent_app_number] => 10829390
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/829390 | 8β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes | Apr 21, 2004 | Issued |
Array
(
[id] => 252700
[patent_doc_number] => 07579334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-25
[patent_title] => 'Compounds with anti-inflammatory activity'
[patent_app_type] => utility
[patent_app_number] => 10/830858
[patent_app_country] => US
[patent_app_date] => 2004-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13123
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/579/07579334.pdf
[firstpage_image] =>[orig_patent_app_number] => 10830858
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/830858 | Compounds with anti-inflammatory activity | Apr 21, 2004 | Issued |
Array
(
[id] => 229061
[patent_doc_number] => 07601874
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-13
[patent_title] => 'Indene derivatives as pharmaceutical agents'
[patent_app_type] => utility
[patent_app_number] => 10/825084
[patent_app_country] => US
[patent_app_date] => 2004-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59951
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/601/07601874.pdf
[firstpage_image] =>[orig_patent_app_number] => 10825084
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/825084 | Indene derivatives as pharmaceutical agents | Apr 14, 2004 | Issued |
Array
(
[id] => 6967127
[patent_doc_number] => 20050234024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Materials and methods for the treatment of ulcerative colitis'
[patent_app_type] => utility
[patent_app_number] => 10/823906
[patent_app_country] => US
[patent_app_date] => 2004-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9218
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20050234024.pdf
[firstpage_image] =>[orig_patent_app_number] => 10823906
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/823906 | Materials and methods for the treatment of ulcerative colitis | Apr 13, 2004 | Abandoned |
Array
(
[id] => 7089681
[patent_doc_number] => 20050009794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Crystals of a vitamin D derivative and a method for the preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 10/821973
[patent_app_country] => US
[patent_app_date] => 2004-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6389
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009794.pdf
[firstpage_image] =>[orig_patent_app_number] => 10821973
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/821973 | Crystals of a vitamin D derivative and a method for the preparation thereof | Apr 11, 2004 | Abandoned |
Array
(
[id] => 112709
[patent_doc_number] => 07713951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-11
[patent_title] => '2-alkylidene-18,19-dinor-vitamin D compounds'
[patent_app_type] => utility
[patent_app_number] => 10/821828
[patent_app_country] => US
[patent_app_date] => 2004-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12016
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/713/07713951.pdf
[firstpage_image] =>[orig_patent_app_number] => 10821828
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/821828 | 2-alkylidene-18,19-dinor-vitamin D compounds | Apr 8, 2004 | Issued |